PCSK9 and familial hyperaldosteronism: Characterized by lifelong elevated LDL-C levels, FH manifests in two primary clinical forms: heterozygous FH (HeFH) and homozygous FH (HoFH), both attributable to mutations in the LDL receptor (LDLR), APOB, and PCSK9 genes [30].